Skip to main content

Advertisement

SpringerLink
Log in

Sentinel lymph node biopsy in breast cancer: the node to recovery

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

The widespread adoption of sentinel lymph node biopsy to stage the axilla has led to decrease in arm and shoulder morbidity. Sentinel lymph node biopsy is suitable for patients with clinically/radiologically node negative invasive breast cancer and selected patients with DCIS (those with clinical/radiological mass or extensive lesions requiring mastectomy). The combined isotope-blue dye injection technique gives the best results. We inject the isotope intra-dermally preoperatively and blue dye dye subdermally after anesthetic induction into the tumour quadrant peri-areolar tissue. Lymphoscintiscan is not necessary but is useful during the learning phase. Sentinel node biopsy can be performed through a small transverse or vertical axillary incision (∼3 cm) appropriately placed to allow axillary lymph node clearance if needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993; 2:335–339.

    Article  CAS  PubMed  Google Scholar 

  2. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 1994; 220:391–398.

    Article  CAS  PubMed  Google Scholar 

  3. Albertini JJ, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818–1822.

    Article  CAS  PubMed  Google Scholar 

  4. Gill G. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol. 2009;16:266–275.

    Article  PubMed  Google Scholar 

  5. Krag DN, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillarylymphnode dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881–888.

    Article  CAS  PubMed  Google Scholar 

  6. Mansel RE et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609.

    Article  PubMed  Google Scholar 

  7. Purushotham AD, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005;23:4312–4321.

    Article  PubMed  Google Scholar 

  8. Veronesi U, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–553.

    Article  PubMed  Google Scholar 

  9. Zavagno G, et al. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg. 2008;247:207–213.

    Article  PubMed  Google Scholar 

  10. Goyal A, et al. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res Treat. 2006;98:311–314.

    Article  PubMed  Google Scholar 

  11. Specht MC, Fey JV, Borgen PI, Cody HS, III. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg. 2005;200:10–14.

    Article  PubMed  Google Scholar 

  12. Cody HS III, et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol. 2001;8:13–19.

    Article  PubMed  Google Scholar 

  13. Goyal A, Newcombe RG, Chhabra A, Mansel RE. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203–208.

    Article  PubMed  Google Scholar 

  14. Hung WK, et al. Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer. Br J Surg. 92:1494–497.

  15. Derossis AM, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 2001;193:473–478.

    Article  CAS  PubMed  Google Scholar 

  16. McMasters KM, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg. 2001;233:676–687.

    Article  CAS  PubMed  Google Scholar 

  17. Klimberg VS, et al. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg. 1999;229:860–864.

    Article  CAS  PubMed  Google Scholar 

  18. Povoski SP, et al. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol. 2006;13:1412–1421.

    Article  PubMed  Google Scholar 

  19. Rodier JF, et al. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial. J Clin Oncol. 2007;25:3664–3669.

    Article  PubMed  Google Scholar 

  20. McCarter MD, et al. Localization of the sentinel node in breast cancer: identical results with sameday and day-before isotope injection. Ann Surg Oncol. 2001;8:682–686.

    Article  CAS  PubMed  Google Scholar 

  21. Goyal A, et al. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer. 2005;41:238–243.

    Article  PubMed  Google Scholar 

  22. Martin RC, Fey J, Yeung H, Borgen PI, Cody HS III. Highest isotope count does not predict sentinel node positivity in all breast cancer patients. Ann Surg Oncol. 2001;8: 592–597.

    Article  CAS  PubMed  Google Scholar 

  23. Goyal A, Newcombe RG, Mansel RE. Clinical relevance of multiple sentinel nodes in patients with breast cancer. Br J Surg. 2005;92:438–442.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK

    Amit Goyal

Authors
  1. Amit Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amit Goyal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goyal, A. Sentinel lymph node biopsy in breast cancer: the node to recovery. Indian J Surg Oncol 1, 10–13 (2010). https://doi.org/10.1007/s13193-010-0005-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-010-0005-y

Keywords

Search

Navigation